SCHEMBL6777623

SCHEMBL6777623

NC(=O)c1ccc(NCc2ccccc2O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.63
CA2 P00918 2/20 0.63
CA9 Q16790 2/20 0.63
HIF1A Q16665 2/20 0.63
CA1 P00915 1/20 0.63
ALOX15 P16050 1/20 0.62
MAPT P10636 5/20 0.61
NOX4 Q9NPH5 2/20 0.56
RAB9A P51151 2/20 0.52
MEN1 O00255 1/20 0.52
HTT P42858 1/20 0.52
KMT2A Q03164 1/20 0.52
EGFR P00533 1/20 0.52
APP P05067 1/20 0.51
HPGD P15428 1/20 0.49
SYK P43405 2/20 0.48
GAA P10253 1/20 0.48
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5273870 0.85 HIF1A (0.69) CA12CA2CA9HIF1ACA1
SCHEMBL11593766 0.84 MAPT (0.81) CA12CA2CA9HIF1ACA1
SCHEMBL30765134 0.83 SMN1; SMN2 (0.62) HIF1ACA1MAPTRAB9AMEN1
SCHEMBL6255527 0.81 EGFR (0.71) MAPTNOX4EGFRSYKHSP90AA1
SCHEMBL25442713 0.81 HKDC1 (0.70) CA12CA2CA9HIF1ACA1
SCHEMBL10781073 0.79 MAPT (0.73) CA12CA2CA9HIF1ACA1
SCHEMBL28133929 0.79 HIF1A (0.61) CA12CA2CA9HIF1ACA1
SCHEMBL802584 0.79 HIF1A (0.74) CA12CA2CA9HIF1ACA1
SCHEMBL30208389 0.79 HIF1A (0.74) CA12CA2CA9HIF1ACA1
SCHEMBL25167180 0.77 CA2 (1.00) CA12CA2CA9HIF1ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800590-B2 CHEMICAL HERBICIDES IN AGRICULTURE SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2004-10-05 US disclosed
US-20030220198-A1 2-pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses ZHEIJIANG CHEMICAL INDUSTRY RESEARCH INSTITUTE (CN) 2003-11-27 US disclosed
EP-1327629-A1 NEW 2-PYRIMIDINYLOXY-N-ARYL-BENZYLAMINE DERIVATIVES, THEIR PROCESSES AND USES SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2003-07-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220198-A1 2-pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses CBR3, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CA12 2646/4885CA2 60/4885CA9 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.